乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Cardiology >

CHF

News, opinions and meeting coverage in cardiology.

<乌鸦传媒>Wise Buy? Left Ventricular Assist Devices

Getting better and cheaper, but 'nobody wears pink ribbons for heart failure'

<乌鸦传媒>Subclavian TAVR Safe When Femoral Access Is Risky

Trial analysis shows similar morbidity, mortality

<乌鸦传媒>SAVR Beats Expectations in Intermediate Risk Trial

Lower mortality than surgical risk score predicted in PARTNER 2A

<乌鸦传媒>Novartis Pulls Out of Controversial Entresto Contest

Cardiologists named to review panel had quit

<乌鸦传媒>CMS to Offer Billing Code for Heart Failure Specialists

Should eliminate denials for appearance of double-billing

<乌鸦传媒>Trial: No Benefit for High-Dose Diuretic in Acute HF

But phase II results might not be the final word

<乌鸦传媒>AHA: No Pump Thrombosis With Next-Gen LVAD?

Better outcomes in HeartMate 3 trial hinged on fewer malfunctions

<乌鸦传媒>AHA: Real World TAVR Is All About Patient Selection

Intermediate risk is a moving target

<乌鸦传媒>AHA: Long-Term Benefit in HF Patients Elusive for Novel Vasodilator

Investigational drug ularitide had no effect on mortality or clinical outcomes

<乌鸦传媒>TCT: TAVR Holds Up Pretty Well Over Time

Also, 2-year data confirm lasting improvements in QoL

<乌鸦传媒>TCT: Embolic Protection Flops for TAVR

New brain lesions or clinical strokes unaffected in SENTINEL trial

<乌鸦传媒>CardioBrief: Impella No Better Than IABP in Cardiogenic Shock

Underpowered IMPRESS trial shows no mortality benefit

<乌鸦传媒>HFSA: Clinical Benefits Tied To Lung Monitoring Persist

HF rehospitalization, deaths remain reduced up to 4.5 years

<乌鸦传媒>Cardiac Myosin Activator Shows Promise for LV Function

'More hands pulling on the rope'

<乌鸦传媒>HFSA: Did LAP Monitoring Cut HF Rehospitalizations?

LAPTOP-HF investigators tried to make sense of terminated study

<乌鸦传媒>ESC: Beta-Blocker Cuts Early Heart Damage from Cancer Tx?

No clinical difference in small trial, but preclinical measures suggestive

<乌鸦传媒>ESC: No Mortality Benefit With ICD in Nonischemic HF

Eleven fewer deaths over 5 years

<乌鸦传媒>Stores' Security Systems Can Mess With Cardiac Devices

ICD, pacemaker hiccups seen near anti-shoplifting monitors in lab study

<乌鸦传媒>Survival Rates Good With VAD for Complicated Acute MI

Despite being sicker to start, outcomes on par with other VAD patients

<乌鸦传媒>Podcast: 10th Anniversary for HealthNewsReview.org

Gary Schwitzer reflects on high points, low points, lessons learned

<乌鸦传媒>ACC: After a Decade, CABG Pulls Ahead of Meds for HF

Life-saving benefit of CABG now clear in long-term trial follow-up

<乌鸦传媒>Entresto: Why Is There Silence? We're Not Selling iPhones

The drug hailed as a true PARADIGM shift, is slow out of the gate

<乌鸦传媒>ACC: TAVR Once Again Non-Inferior to Surgery

No excess stroke or mortality at 2 years in lowest risk trial population yet studied

<乌鸦传媒>CardioBrief: Top HF Expert Decries 'Unbelievable Folly' of Clinical Trials and Guidelines

Milton Packer, MD, calls the system to test and evaluate heart failure drugs dysfunctional

<乌鸦传媒>CardioBrief: LVADs Prolong Life But Sow Confusion at Its End

Uncertainty dogs heart pump patients and their caregivers

<乌鸦传媒>First MRI-Safe CRT-D Devices Approved

Cardiac resynchronization patients may now undergo scans

<乌鸦传媒>CardioBrief: Entresto Maker in Deep Water Over Terrifying TV Ad

"Alarmist," "horrifying" and "irresponsible," experts say

<乌鸦传媒>CardioBrief: Entresto Off to Slow Start

'Blockbuster' heart failure drug falls short of already low sales expectations

<乌鸦传媒>AHA: Long-Acting Nitrate Flops in HFpEF

Study does not support the use of nitrates in subgroup of heart failure patients

<乌鸦传媒>Is SAMHSA to Blame for a Broken Mental Health System?

Two members of Congress differ on how to fix a failing system

<乌鸦传媒>Safety Warning: Watch LVAD Battery Expiration

Ventricular support backup battery issue linked to two deaths

<乌鸦传媒>Clear Health Costs: Having Insurance Doesn't Always Pay

The case of the $1,700 mammogram

<乌鸦传媒>CardioBrief: Dollars for Heart Docs

Analysis of CMS database shows some docs pocketed millions from drug and device makers.

<乌鸦传媒>10 Questions: Mary Norine Walsh, MD

"The waste will continue until the method of reimbursement changes."

<乌鸦传媒>Hyperkalemia Pipeline Promising

Novel agents look good in trials, although long-term safety and efficacy remain to be seen.

<乌鸦传媒>Doctor's Memoir Exposes Dark Side of Medicine

Sandeep Jauhar puts his life on stark display to illustrate harmful financial intrusions into medicine in his newest book.

<乌鸦传媒>CardioBuzz: Toward the $500 an Hour Physician

In this guest blog, Mark Jay Zucker, MD, JD, an attorney and transplant cardiologist at Rutgers University New Jersey Medical School in Newark, explains why he thinks it's time to talk money.

<乌鸦传媒>How To Get Medicare To Cover A Spa Trip

Good news for doctors who think their patients need a trip to the spa: Medicare will reimburse, with only two catches.

<乌鸦传媒>How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

<乌鸦传媒>CT Appears Safe in Patients With Pacemakers, ICDs

Patients with cardiac rhythm management devices showed no clinically significant major or minor events related to computed tomography imaging over a 10-year period at two large-volume care centers, researchers reported.

鈥�

17